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microanatomy and biology of haemopoiesis, moves to 
accounts of the receptor technology and molecular biology of 
the principal colony stimulating factors and concludes with a 
series of chapters on the clinical applications of CSFs (with 
associated problems of large scale production of protein 
pharmaceuticals), CSF signal transduction and control of 
gene expression. “Colony Stimulating Factors” can therefore 
be highly recommended as a generally accessible and wide- 
ranging compendium of information on CSFs which conveys 
an excellent feel for the successes, problems and future 
directions of this exciting area of modern biology. 
The book, however, is not without its faults. There is an 
inevitable duplication of information and unevenness of 
level; the ‘splice sites’ in certain chapters with multiple 
authors are painfully obvious and whereas some chapters are 
readable and informative, others are highly detailed and 
somewhat indigestible. It is not clear, for example, how many 
readers will wish to wile away a long flight perusing the 
complete genomic sequence of GM-CSF. The other problem 
is that the book is already in certain areas out of date. It 
seems the book was completed in 1988 and developments in 
certain areas, particularly the cloning of CSF receptors, 
whilst anticipated in the editor’s excellent summary chapter, 
are now a reality. For this reason, the most durable aspect of 
the volume may prove to be those chapters (e.g. Allen et al. 
on bone marrow biology and Steward et al. on clinical trials) 
with an analytical and broadly based approach. Finally, both 
the indexing and proofreading are firmly from the minimalist 
school of academic publishing, which is rather irritating for 
a volume costing $162 (in Europe). 
John K. Heath 
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Haemopoiesis is one of the principal areas where molecular 
biology is beginning to make a direct impact on clinical 
medicine. A discipline that was firmly rooted in cell biology 
has warmly embraced the new molecular approach and this 
has increased the pace of progress towards an understanding 
of the mechanisms controlling both the normal and 
pathological aspects of this extremely complex process. In 
May 1989 the CIBA Foundation brought together many of 
the world’s leading research workers in this field, not just 
from Europe and North America but also from the Southern 
hemisphere, since Australians have provided a major 
contribution to dissecting the regulation of haemopoiesis over 
the last 25 years. This book is the published proceedings of 
that symposium, and if it has an overall message, it is that 
however far the field has progressed, it has an awful lot 
further to go. 
Haemopoiesis can be considered as a triangle, the base 
being all the mature cells of the peripheral blood (plus some 
cells in other tissues) and the apex the haemopoietic stem cell, 
a cell with the capability to differentiate down several 
different pathways and with an extremely high proliferative 
capacity. Our understanding about how the pluripotent stem 
cell ends up as a fully differentiated end cell remains limited 
and the best understood steps are those late in the pathway, 
towards the base of the triangle. Many of the growth factors 
needed for these steps have now been cloned (and therefore 
can be produced in relatively large amounts), as have a few 
of their receptors. Many of the haemopoietic growth factors 
are produced by the haemopoietic cells themselves and the 
factors have pleiotropic effects, including influencing factor 
release from other haemopoietic cells. Clearly, therefore, 
haemopoiesis is no simple hierarchical process but rather a 
cascade of interactions and thus it is not surprising that our 
current understanding remains limited. 
The molecular control of haemopoiesis may be complex 
and the basic biology of the system may only be known in 
outline but that has not prevented the use of some of the 
haemopoietic growth factors in treating disease. The use of 
recombinant erythropoietin in the treatment of the anaemia 
of renal disease is now almost routine in many countries and 
numerous groups are studying the beneficial effects of 
granulocyte colony stimulating factors on shortening the 
period of granulocytopenia following chemotherapy or bone 
marrow transplantation. These are early, somewhat 
empirical, trials which provide valuable data on the in vivo 
effects in man. 
Many of these issues are addressed in this book, which is 
not a series of reviews (and suffers from the lack of an 
overview of the whole area), but rather, a series of random 
snapshots of various parts of haemopoiesis, authoritatively 
written and of a generally high standard, but lacking in 
cohesiveness. As such it is difficult to identify its intended 
readership, since the topics covered are somewhat selective. 
For those in the haemopoiesis field there will be lots to savour 
and for those in related areas it will provide a good flavour 
of where this rapidly moving field was in 1989. 
W.G. Wood 
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This volume in the successful “Practical Approach” series 
comprises 10 chapters presenting practical methodology used 
in studies on the growth and division of animal cells in 
culture. Most of the information provided relates to specific 
cell lines: chapters are devoted to culture of mouse embryo 
cells, mouse fibroblast lines (C3H lOTI/ and NIH 3T3), 
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